September 2026
Independent · Evidence-based
Department · Joints
Joints & Mobility
Moving well after fifty — what the research on joint pain, stiffness, and the supplement aisle actually supports, and what it doesn't.
The Lead
Glucosamine and chondroitin: what the biggest trial actually found
The best-selling joint ingredients in the world got the largest test the NIH could build — 1,583 people, five arms, a real placebo, and a two-year follow-up. We read the results the packaging never mentions.
More in Joints
5 reports
Why joints ache after fifty — and what “wear and tear” gets wrong
The tire-tread story is decades out of date. What's actually happening is more hopeful.
The best-studied answer to achy joints is movement
No pill has evidence close to this deep — and walking doesn't wear knees out.
Collagen for joint pain: what the studies show — and what they don't
Real trials, small and mostly industry-funded. The honest read on the decade's favorite.
Turmeric and joint pain: real trials, modest effects, three asterisks
More human evidence than most of the aisle — plus the three catches the label skips.
When joint pain is worth a doctor's visit
Ordinary aches versus the short list of signs that shouldn't wait for Monday.
How we review
Every joints report is read against published research and clinical guidelines. We hedge what's uncertain, cite real sources, and label any advertorial plainly — promising is never reported as proven.